Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $15.3650 (-1.6%) ($15.3650 - $15.3650) on Mon. Jul. 19, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.45% (three month average) | RSI | 49 | Latest Price | $15.3650(-1.6%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.6% a day on average for past five trading days. | Weekly Trend | BCRX declines -1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(45%) IBB(40%) IWO(38%) ARKK(37%) ARKG(36%) | Factors Impacting BCRX price | BCRX will decline at least -2.225% in a week (0% probabilities). VIXM(-23%) UUP(-14%) VXX(-7%) TBT(-2%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.225% (StdDev 4.45%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $9.64(-37.26%) | Resistance Level | $16.13 | 5 Day Moving Average | $15.66(-1.88%) | 10 Day Moving Average | $15.87(-3.18%) | 20 Day Moving Average | $16.13(-4.74%) | To recent high | -10.8% | To recent low | 44.2% | Market Cap | $2.711b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |